BeStock  
Stocks › Biotechnology › AAPG

Ascentage Pharma AAPG

US equityMarket cap rank #3080Biotechnology
$11.97 −$0.47 (-3.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.97 0.00%
Open$12.26
Prev close$12.44
Day range$11.97 – $12.26
Volume5,039
Market cap$1.12B
P/E (TTM)–
Dividend yield–

AAPG Stock News

Headlines matching Ascentage Pharma or the AAPG ticker, most recent first.

  • B. Riley Securities Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45Market news · 2 Sep 2026 · Direct mention
  • Oppenheimer Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45Market news · 21 Aug 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)TipRanks · 21 Aug 2026 · Direct mention
  • BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48Market news · 21 Aug 2026 · Direct mention
  • Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy RatingMarket news · 21 Aug 2026 · Direct mention
  • Oppenheimer Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45Market news · 15 Jun 2026 · Direct mention
  • B. Riley Securities Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45Market news · 10 Jun 2026 · Direct mention
  • Piper Sandler Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48Market news · 1 Jun 2026 · Direct mention
  • Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $22.34 NegativeMarket news · 24 Apr 2026 · Direct mention
  • Deutsche Bank Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $40Market news · 24 Apr 2026 · Direct mention
  • J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $46 NegativeMarket news · 16 Apr 2026 · Direct mention
  • Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $51Market news · 27 Mar 2026 · Direct mention
  • BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48Market news · 12 Mar 2026 · Direct mention
  • BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48Market news · 6 Nov 2026 · Direct mention
  • J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $33 NegativeMarket news · 9 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AAPG.

Sign in to join the discussion.

Scroll to Top